BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
This Quarter Return
-15.93%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$75.6M
AUM Growth
+$75.6M
(-3%)
Cap. Flow
-$1.84M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$1.12M |
| 2 |
MBVX
MABVAX THERAPEUTICS HLDGS INC
MBVX
|
$723K |
Sector Composition
| 1 | Healthcare | 13.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $65.1M | 86.12% |
2,168,601
-37,325
| -2% | -$1.12M |
|
2
ADMA Biologics
ADMA
$4.1B
| $10.4M | 13.73% |
1,433,304
| – | – |
|
|
MBVX
3
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $113K | 0.15% |
26,708
-170,933
| -86% | -$723K |
|